Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-21

Clinical Trial Update: Comparison Efficacy of 14-day Triple Therapy: Clarithromycin vs. Levofloxacin on Eradication of H. Pylori [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing 14-day triple therapy regimens using clarithromycin versus levofloxacin to eradicate Helicobacter pylori.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levofloxacin (Levofloxacin)
  • clarithromycin (clarithromycin)

Snippet

Sponsor: Damascus Hospital | Conditions: Helicobacter Pylori Gastrointestinal Tract Infection | Phase 4 | Status: UNKNOWN